Laser microprobe analysis of brain aluminum in Alzheimer' disease
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Aluminum (Al) levels were measured in the cytoplasm and nucleus of 241 neurofibrillary tangle (NFT)‐bearing neurons, in 217 NFT‐free neurons and adjacent neuropil from 7 autopsy‐confirmed Alzheimer's disease (AD) patients, and in 316 normal neurons from 5 control subjects, by laser micriprobe mass spectrometry. Grand mean Al levels (dry weight basis) in AD samples were 2.93 ± 1.24 μg/gm for NFT‐bearing neuron cytoplasm, 3.54 ± 1.39 μg/gm for NFT‐bearing neuron nuclei, 2.31 ± 1.09 μg/gm for NFT‐free neuron cytoplasm, and 3.23 ± 1.09μg/gm for NFT‐free neuron nuclei. Control values were 1.85 ± 0.78 μg/gm for cytoplasm and 2.01 ± 0.93 μg/gm for nuclei. The differences between corresponding regions of AD NFT‐bearing, AD NFT‐free, and control neurons were not significant (p > 0.05, analysis of variance). Al levels in neuropil were identical for AD and control samples at 2.16 ± 0.93 μg/gm. In contrast to some literature reports, we found very few (<2.5%) extremely high Al values (>20μg/gm, dry weight) on a cellular basis in AD samples. AD neurons did exhibit a higher number of Al values (9.6−14.3%) that were >sgrave; above the corresponding control means, than did control neurons (1.3–1.6%), indicating that small elevations of Al may exist in patients with AD. Our data suggest that any Al accumulation in patients with AD is small and generalized in both NFT‐free and NFT‐bearing neurons and that analyses of large bulk brain samples are likely to have AD/control differences masked by the large amount of unaffected neuropil sampled.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnosis of Alzheimer's Disease
Khachaturian, Z. S. (1985) · Archives of Neurology · doi:10.1001/archneur.1985.04060100083029 · Cited by 2,499
Good, P. F., Perl, D. P., Bierer, L. M., & Schmeidler, J. (1992) · Annals of Neurology · doi:10.1002/ana.410310310 · Cited by 476
Cited by
Human Health Risk Assessment for Aluminium, Aluminium Oxide, and Aluminium Hydroxide
Krewski, D., Yokel, R. A., Nieboer, E., Borchelt, D., Cohen, J., Harry, J., Kacew, S., Lindsay, J., Mahfouz, A. M., & Rondeau, V. (2007) · Journal of Toxicology and Environmental Health, Part B · doi:10.1080/10937400701597766 · Cited by 998
The redox chemistry of the Alzheimer's disease amyloid β peptide
Smith, D. G., Cappai, R., & Barnham, K. J. (2007) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.02.002 · Cited by 608
Alzheimer's disease, metal ions and metal homeostatic therapy
Zatta, P., Drago, D., Bolognin, S., & Sensi, S. L. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.05.002 · Cited by 369
Are reactive oxygen species involved in Alzheimer's disease?
Benzi, G. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)00066-n · Cited by 365
Scott, L. E., & Orvig, C. (2009) · Chemical Reviews · doi:10.1021/cr9000176 · Cited by 332
Metadata
- Authors
- Lovell, M. A., Ehmann, W. D., & Markesbery, W. R.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 1993-01
- Volume
- 33
- Issue
- 1
- Pages
- 36-42
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W1983761283
- Cited by
- 120
- References
- 2
- FWCI
- 4.78
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Laser microprobe analysis of brain aluminum in Alzheimer' disease. https://app.cochat.ai/papers/10.1002/ana.410330107
- The paper
- Lovell, M. A., Ehmann, W. D., & Markesbery, W. R. (1993). Laser microprobe analysis of brain aluminum in Alzheimer' disease. Annals of Neurology. https://doi.org/10.1002/ana.410330107
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.